Mechanistic In Silico and In Vitro Evaluation of Phytochemicals Targeting HIV-1 Reverse Transcriptase and Protease
International Journal of Drug Delivery Technology · 21.04.2026 · 16 (15s)
DOI: 10.25258/ijddt.16.15s.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 21.04.2026. Verfasst von Manisha Kotadiya und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Human immunodeficiency virus type-1 (HIV-1) replication depends on the coordinated activity of viral enzymes, particularly reverse transcriptase and protease, which are critical for genome replication and viral maturation. Targeting these enzymes remains a central strategy in antiviral drug development. Materials and Methods: In the present study, an integrated in silico–in vitro approach was employed to investigate plant-derived phytochemicals as potential inhibitors of HIV-1 reverse transcriptase and protease. Molecular docking was performed to predict binding affinities and interaction patterns of selected phytochemicals with the catalytic regions of both enzymes. Drug-likeness and pharmacokinetic properties were evaluated using ADMET and SwissADME tools, while biological activity was predicted using PASS analysis. Results and Discussion: Experimental validation was carried out using enzyme-based inhibition assays, complemented by cytotoxicity assessment in host cells using the MTT assay. Docking analyses revealed stable and target-specific interactions of phytochemicals with key amino acid residues involved in enzyme activity. In vitro assays confirmed inhibitory effects with IC₅₀ values ranging from 2.0 to 30.0 μM, alongside acceptable cytotoxicity profiles. Several compounds demonstrated differential inhibition of reverse transcriptase and protease, indicating distinct modes of interference with HIV-1 replication machinery.
Conclusion
Overall, this study provides mechanistic insight into the inhibition of HIV-1 enzymes by structurally diverse phytochemicals and establishes a direct correlation between predicted molecular interactions and functional enzyme inhibition. The findings highlight the potential of natural compounds as lead scaffolds for structure-guided antiviral drug development targeting HIV-1 pathogenesis.
Zitieren
APA
Kotadiya, M., Lakhani, R., Trivedi, D., Prajapati, R., Patel, R., Vyas, N., Chavda, H., & Patel, M. S. (2026). Mechanistic In Silico and In Vitro Evaluation of Phytochemicals Targeting HIV-1 Reverse Transcriptase and Protease. International Journal of Drug Delivery Technology, 16(15s). https://doi.org/10.25258/ijddt.16.15s.76
Vancouver
Kotadiya M, Lakhani R, Trivedi D, Prajapati R, Patel R, Vyas N, et al. Mechanistic In Silico and In Vitro Evaluation of Phytochemicals Targeting HIV-1 Reverse Transcriptase and Protease. International Journal of Drug Delivery Technology. 2026;16(15s). doi:10.25258/ijddt.16.15s.76
BibTeX
@article{Kotadiya2026,
author = {Kotadiya, Manisha and Lakhani, Reshma and Trivedi, Devanshi and Prajapati, Riddhi and Patel, Riya and Vyas, Namrata and Chavda, Hirva and Patel, Manali Sunilbhai},
title = {Mechanistic In Silico and In Vitro Evaluation of Phytochemicals Targeting HIV-1 Reverse Transcriptase and Protease},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {15s},
doi = {10.25258/ijddt.16.15s.76}
}
EUVIMED